MBIA (MBI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
7 Apr, 2026Executive summary
Lower net losses reported for full year 2025 compared to 2024, with comparable net losses in Q4 year-over-year.
National recorded a benefit from losses and loss adjustment expense (LAE) in 2025, mainly due to favorable PREPA-related developments.
PREPA exposure remains a key focus, with limited progress on legal resolutions since November.
Strategic options, including a potential sale of the company or its components, remain under consideration to maximize shareholder value.
Released full year and Q4 2025 financial results, available on company and SEC websites.
Financial highlights
Consolidated GAAP net loss for Q4 2025 was $51 million ($-1.01/share), unchanged from Q4 2024 ($-1.07/share).
Adjusted net loss for Q4 2025 was $12 million ($-0.24/share), improved from $22 million ($-0.48/share) in Q4 2024.
Full year 2025 consolidated GAAP net loss was $177 million ($-3.58/share), down from $447 million ($-9.43/share) in 2024.
Adjusted net income for full year 2025 was $23 million ($0.46/share), versus an adjusted net loss of $184 million ($-3.90/share) in 2024.
Book value per share decreased by $3.28 to negative $44.27 as of December 31, 2025.
Outlook and guidance
PREPA exposure reduction and portfolio runoff are expected to improve the likelihood and size of potential special dividends.
Substantive progress on PREPA restructuring is unlikely until legal issues with the Oversight Board are resolved.
All strategic options, including sale of the company or its parts, remain open depending on shareholder value.
Latest events from MBIA
- Net loss narrowed to $40M in Q1 2026, with stable liquidity and ongoing PREPA risk.MBI
Q1 20268 May 2026 - All proposals passed, re-electing directors and approving compensation and auditor.MBI
AGM 20266 May 2026 - Audit fees correction and voting update highlighted for the 2026 annual meeting.MBI
Proxy filing2 Apr 2026 - Virtual annual meeting to vote on directors, pay, and auditors, with strong governance focus.MBI
Proxy filing23 Mar 2026 - Q3 2024 net loss narrowed to $56M, but PREPA risks and negative book value persist.MBI
Q3 202412 Feb 2026 - 2024 net loss narrowed, but adjusted losses rose and PREPA uncertainty persists.MBI
Q4 202412 Feb 2026 - Q2 net loss hit $254M on PREPA charges; book value fell to negative $39.07.MBI
Q2 20242 Feb 2026 - Annual meeting to vote on directors, pay, auditors, and incentive plan; board is majority independent.MBI
Proxy Filing2 Dec 2025 - Net loss narrowed, PREPA claim marketability improved, but litigation uncertainty persists.MBI
Q2 202523 Nov 2025